| Drug Name | Mircera® (Methoxy polyethylene glycol-epoetin beta) |
|---|---|
| Drug Class |
Hematopoietic growth factor
|
| Risk minimization type |
Direct Healthcare Professional Communication DHPC
|
| Specialty (Theraputic area) |
Hematology
|
| Risk |
Severe cutaneous adverse reactions (SCARs) |
| Dear Healthcare provider letter DHPC |
|